Macy’s, Inc. (NYSE: M) reported fourth quarter 2020 earnings results today.
Net sales totaled $6.7 billion compared to $8.3 billion in the same period last year.
Comparable sales were down 17% on an owned basis and down 17.1% on an owned plus licensed basis.
The company reported a GAAP net profit of $160 million, or $0.50 per share, compared to a net income of $340 million, or $1.09 per share, last year.
The adjusted net profit was $253 million, or $0.80 per share.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key